Advertisement

Advertisement

Most Read Stories
Long-Term Results With Local Consolidative Therapy vs Maintenance Therapy or Observation in Oligometastatic NSCLC
SUNSHINE Trial: High-Dose Vitamin D May Benefit Patients With Metastatic Colorectal Cancer
Evidence Builds for Treating Smoldering Myeloma
Trastuzumab Deruxtecan in Advanced HER2-Positive Gastric and Breast Cancers
TRINOVA-3: Addition of Trebananib to Carboplatin/Paclitaxel as First-Line Treatment for Advanced Ovarian Cancer
IMmotion151: First-Line Atezolizumab/Bevacizumab vs Sunitinib in Metastatic Renal Cell Carcinoma
Early-Stage Study of Nivolumab Alone or in Combination With Cisplatin/Gemcitabine in Biliary Tract Cancer
Prostate-Only vs Whole-Pelvis Radiotherapy in Gleason Grade 5 Prostate Cancer
OPTIMISMM: Addition of Pomalidomide to Bortezomib/Dexamethasone in Pretreated Relapsed or Refractory Multiple Myeloma
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Incoming ASCO President Sets His Sights on Conquering Cancer
ASTRO and AUA Announce Updates to Joint Clinical Guidance for Adjuvant and Salvage Radiotherapy After Prostatectomy
Alterations in the RB1 Gene and Outcomes in Metastatic Castration-Resistant Prostate Cancer
Digital Breast Tomosynthesis vs Digital Mammography in a Breast Cancer Screening Program
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
NCCN Clinical Practice Guidelines in Oncology: 2019 Updates
'Oral Cryotherapy' for Patients Undergoing Oxaliplatin-Based Chemotherapy
Management of HER2-Positive Breast Cancer: Business as Usual?
ACCURE Trial: Improving Racial Disparities in Treatment for Patients With Early-Stage Lung and Breast Cancers
Predicting Response to Immunotherapy in Squamous Cell Carcinoma

Advertisement

Advertisement



;
Advertisement